Oral formulations of pyrrolidine derivatives Grant US-11419851-B2 United States of America 23 Aug 2022
Pyrrolidine derivatives as oxytocin/vasopressin via receptors antagonists Grant US-11312683-B2 United States of America 26 Apr 2022